Longitudinal Changes in Patient Distress following Interactive Decision Aid Use among <i>BRCA1/2</i> Carriers
Gillian W. Hooker(National Institutes of Health), Marc D. Schwartz(Guardia Civil), Tiffani A. DeMarco(Georgetown University), Clinton Finch(Georgetown University), Erica Wahl(University of Maryland, Baltimore), Karen Brown(University of Leicester), Heiðdís Valdimarsdóttir(Reykjavík University), Beth N. Peshkin(Georgetown University), Jessica Rispoli Joines(University of Maryland, Baltimore), Kara‐Grace Leventhal(University of Maryland, Baltimore)
Cited by 60
Related Papers
The Group-Based Medical Mistrust Scale: psychometric properties and association with breast cancer screening
|Preventive Medicine|2003|495
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
|PLoS ONE|2011|437
Depressive symptoms, mental wellbeing, and substance use among adolescents before and during the COVID-19 pandemic in Iceland: a longitudinal, population-based study
|The Lancet Psychiatry|2021|302
Randomized Noninferiority Trial of Telephone Versus In-Person Genetic Counseling for Hereditary Breast and Ovarian Cancer
|Journal of Clinical Oncology|2014|253
Impact of <i>BRCA1</i>/<i>BRCA2</i> Counseling and Testing on Newly Diagnosed Breast Cancer Patients
|Journal of Clinical Oncology|2004|250